7Baggers

Nano Dimension Ltd
(NASDAQ:NNDM) 

NNDM stock logo

Nano Dimension Ltd., together with its subsidiaries, provides additive electronics in Israel and internationally. Its flagship product is the proprietary DragonFly lights-out digital manufacturing (LDM) system, a precision system that produces professional multilayer circuit-boards, radio frequency ...

Founded: 2012
Full Time Employees: 68
CEO: Yoav Stern  
Sector: Technology
Industry: Computer Hardware
Technology3D Printing
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-11-19 2025-09-17 2025-06-12 2024-12-31 2024-11-20 2024-08-20 2024-06-30 2024-06-03 2024-03-21 2023-12-31 2023-09-30 2023-06-30 2023-06-29 2022-12-31 2022-12-01 2022-09-01 2022-05-31 2021-12-31 2021-08-18 2021-05-20 2020-12-31 2020-11-12 2020-06-30 2019-12-31 2019-09-23 2018-12-31 2018-02-15 2017-12-31 2016-12-31 2015-12-31 
                                    
      revenue:
    		                                
      product
    		22,931,000                                
      service
    		6,794,000                                
      total revenue
    		29,725,000                                
      yoy
    		                                
      qoq
    		                                
      cost of revenue:
    		                                
      total cost of revenue
    		17,598,000                                
      gross profit
    		12,127,000 13,317,000 8,144,000 7,043,000 5,906,000 24,889,000 7,156,000 6,808,000 12,986,000 6,178,000 7,028,000 7,028,000 5,369,000 13,061,000 6,566,000      1,065,000    15,000  213,000      
      yoy
    		105.33% -46.49% 13.81% 3.45% -54.52% 302.87% 1.82% -3.13% 141.87% -52.70% 7.04%          7000.00%            
      qoq
    		-8.94% 63.52% 15.63% 19.25% -76.27% 247.81% 5.11% -47.57% 110.20% -12.09% 0.00% 30.90% -58.89% 98.92%                   
      gross margin %
    		40.80% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% Infinity% NaN% NaN% NaN% NaN% NaN% Infinity% NaN% NaN% NaN% Infinity% NaN% Infinity% NaN% NaN%    
      operating expenses:
    		                                
      research and development
    		8,204,000 7,466,000 8,530,000 8,114,000                             
      sales and marketing
    		9,692,000 10,065,000 10,097,000 9,907,000                             
      general and administrative
    		15,209,000 17,781,000 14,210,000 22,190,000                             
      restructuring
    		3,127,000                                
      desktop metal litigation
    		                                
      impairment losses
    		40,388,000 2,110,000 5,721,000 1,456,000 1,229,000 1,283,000                           
      operating income
    		-64,493,000    -40,088,000 -89,110,000 -20,278,000 -20,836,000 -39,801,000 -18,965,000 -27,265,000 -27,265,000 -35,982,000 -61,633,000 -31,203,000      -35,697,000    -7,274,000  -7,764,000 60,740,000 -45,590,000    
      yoy
    		60.88%    0.72% 369.87% -25.63% -23.58% 10.61% -69.23% -12.62%          390.75%    -84.04%        
      qoq
    		    -55.01% 339.44% -2.68% -47.65% 109.87% -30.44% 0.00% -24.23% -41.62% 97.52%             -112.78% -233.23%     
      operating margin %
    		-216.97% NaN% NaN% NaN% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% NaN% NaN% NaN% NaN% NaN% -Infinity% NaN% NaN% NaN% -Infinity% NaN% -Infinity% Infinity% -Infinity%    
      gain on investment in marketable equity securities
    		-8,435,000 -24,432,000 -2,617,000 16,288,000  -52,256,000                           
      finance income
    		3,512,000 6,703,000 6,674,000 14,352,000 18,035,000 42,573,000 12,704,000 10,535,000 21,846,000 11,311,000 26,904,000 36,342,000 11,101,000 80,780,000 56,826,000      446,000    130,000  47,000 11,000 44,000    
      finance expense
    		-246,000 410,000 -258,000      61,143,000   2,096,250 2,031,000 6,442,000 3,590,000      13,243,000    3,195,000  176,000 722,750 2,891,000    
      income before income taxes
    		-69,662,000 -41,267,000 -29,479,000                              
      income tax expense
    		 30,750 24,000 76,000                             
      net income
    		-69,662,000 -33,942,000 -53,005,000   -99,858,000                           
      yoy
    		 -66.01%                               
      qoq
    		105.24% -35.96%                               
      net income margin %
    		-234.35% -Infinity% -Infinity% NaN% NaN% -Infinity% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN%    
      less: net loss attributable to non-controlling interests
    		                                
      net loss attributable to common shareholders
    		-69,662,000                                
      net loss attributable to common shareholders:
    		                                
      basic and diluted
    		-340                                
      weighted-average common shares outstanding, basic and diluted
    		207,504,000 215,742,000                               
      other comprehensive income:
    		                                
      foreign currency translation adjustment
    		193,000                                
      comprehensive loss
    		-69,469,000                                
      less: comprehensive loss attributable to non-controlling interests
    		                                
      comprehensive loss attributable to common shareholders
    		-69,469,000                                
      see notes to condensed consolidated financial statements.
    		                                
      revenue
    		 16,780,500 26,884,000 25,837,000                             
      cost of revenue
    		 11,523,500 18,740,000 18,794,000                             
      operating expenses
    		                                
      restructuring expense
    		 1,345,750 2,021,000 2,101,000                             
      desktop metal litigation expense
    		 8,002,000 693,000 3,245,000                             
      total operating expenses
    		 34,004,500 41,272,000 47,013,000  113,999,000                           
      income from operations
    		 -28,747,500 -33,128,000                              
      loss from deconsolidation of subsidiaries
    		 -416,500                               
      other income
    		 -273,000 -150,000     2,721,000  109,000 1,627,000                      
      net income from continuing operations
    		 -33,942,000 -29,503,000                              
      net loss from discontinued operations, net of income tax of nil
    		  -23,502,000                              
      loss attributable to non-controlling interests
    		 -80,750   -236,000 -1,029,000 -294,000 -290,000 -480,000 -190,000 -291,000 -291,000 -269,000 -550,000                   
      loss attributable to owners
    		 -64,838,250 -53,005,000  -23,775,000  -8,346,000    -1,049,000 -1,049,000 -66,604,000                    
      basic and diluted loss per share
    		     -0.45                   -0.55  -0.09 -0.22 -0.88    
      net income per share
    		 -0.075 -0.13                              
      basic and diluted income per share
    		        -0.35     0.05                   
      revenues
    		    14,401,000 57,775,000 14,856,000 14,986,000 28,350,000 13,364,000 14,454,000 14,454,000 12,158,000 29,702,000 14,965,000      3,399,000    990,000  1,723,000 3,641,000 1,459,000    
      cost of revenues
    		    8,392,000 31,231,000 7,693,000 8,157,000 15,299,000 7,142,000 7,358,000 7,573,000 6,739,000 16,447,000 8,267,000      1,563,000    589,000  1,124,000 3,102,000 492,000    
      cost of revenues - write-down of inventories and amortization of technology
    		    103,000                            
      total cost of revenues
    		    8,495,000 32,886,000 7,700,000 8,178,000 15,364,000 7,186,000 7,426,000 7,426,000 6,789,000 16,641,000 8,399,000      2,334,000    975,000  1,510,000 624,500 2,498,000    
      research and development expenses
    		    4,977,000 39,558,000 9,801,000 9,121,000 18,254,000 9,133,000 13,580,000 13,580,000 12,788,000 35,636,000 19,250,000      9,878,000    3,597,000  4,611,000 -22,307,000 30,930,000    
      sales and marketing expenses
    		    5,506,000 27,657,000 6,952,000 7,221,000 13,738,000 6,517,000 8,289,000 8,289,000 7,715,000 15,703,000 7,486,000      6,597,000    1,749,000  1,872,000      
      general and administrative expenses
    		    3,472,000 39,535,000 9,960,000 8,581,000 18,183,000 9,602,000 14,051,000 14,051,000 20,848,000 23,355,000 11,033,000      20,287,000    1,943,000  1,494,000      
      other incomes (income)
    		    30,810,000  721,000                          
      finance expenses
    		    1,935,000 -668,000 1,113,000 33,819,000  27,324,000 796,000                      
      income before taxes on income
    		    -23,988,000  -8,687,000 -44,120,000 -79,098,000 -34,978,000 -1,157,000 -1,157,000 -67,146,000 12,705,000 22,033,000                  
      taxes (expenses) benefit
    		    -23,000         -152,000                   
      loss for the period
    		    -24,011,000  -8,640,000    -1,340,000 -13,580,000 -66,873,000                    
      loss per share
    		                                
      basic loss per share
    		    -0.11  -0.05    -0.01 -0.01 -0.26        -1.13            
      other comprehensive income items that after initial recognition in comprehensive income were or will be transferred to profit or loss
    		                                
      foreign currency translation differences for foreign operations
    		    593 -1,944 1,411 -4 -1,708 -1,704 2,024 2,024 -253 597 403                  
      other comprehensive income items that will not be transferred to profit or loss
    		                                
      remeasurement of net defined benefit liability (ias 19), net of tax
    		        -1,433 -1,433 -741 -741  -1,060                   
      total other comprehensive income for the period
    		    593  1,411 -4  -3,137 1,283 -179 -253 -463 403                  
      total comprehensive loss for the period
    		    -23,418  -7,229    -57 -13,759 -67,126                    
      comprehensive loss attributable to non-controlling interests
    		    -224 -1,088 -269 -297 -511 -214 -258 -258 -284 -546 -250                  
      comprehensive loss attributable to owners of the company
    		    -23,194 -103,483 -6,960    201 201 -66,842                    
      cost of revenues - write-down of inventories and amortization of assets recognized in business combination and technology
    		     1,655,000     68,000                      
      other expenses (income)
    		     5,966,000                           
      loss before taxes on income
    		     -99,461,000                           
      taxes expenses
    		     -397,000     -183,000                      
      loss attributable to owners of the company
    		     -98,829,000                           
      weighted-average shares outstanding, basic and diluted
    		     218,311                           
      remeasurement of pension and postretirement benefit plan, net of tax
    		     -2,769                           
      total other comprehensive income for the year
    		     -4,713                           
      total comprehensive loss for the year
    		     -104,571                           
      cost of revenues - write-down of inventories
    		      7,000 21,000 65,000 44,000                       
      tax (expenses) benefit
    		      47,000                          
      taxes benefit
    		       -141,000  16,000  -183,000 273,000  -74,000                  
      income for the period
    		       -44,261,000 -79,223,000 -34,962,000    12,553,000 21,959,000                  
      income attributable to owners
    		       -43,971,000 -78,743,000 -34,772,000    13,103,000 22,222,000                  
      income per share
    		                                
      basic gain per share
    		       -0.2  -0.15                       
      total comprehensive income for the period
    		       -44,265 -82,364 -38,099    12,090 22,362                  
      comprehensive income attributable to owners of the company
    		       -43,968 -81,853 -37,885    12,636 22,612                  
      other incomes
    		        2,612,000                        
      taxes expenses benefit
    		        -125,000                        
      total other comprehensive loss for the period
    		        -3,141                        
      impairment losses on intangible assets
    		                                
      cost of revenues - write-down of inventories and impairment of assets recognized in business combination and technology
    		           61,000 50,000 194,000 132,000                  
      finance income from investment in securities
    		           4,241,750 -40,234,000                    
      income attributable to non-controlling interests
    		              -263,000                  
      basic income per share
    		              0.09                  
      cost of revenues - amortization of intangible
    		                    771,000    386,000  386,000 501,500 2,006,000    
      total comprehensive loss
    		                    -48,494,000    -10,339,000  -7,893,000 63,925,000 -48,437,000    
      tax income
    		                                
      total comprehensive loss after tax
    		                    -48,494,000            
      for the six months ended june 30, 2020:
    		                                
      balance as of january 1, 2020
    		                        65,202        
      issuance of ordinary shares
    		                        -9,743  2,216 292 1,168    
      conversion of convertible notes
    		                        -78        
      exercise of warrants and options
    		                        2,883   12 48    
      share-based payments
    		                        3,484        
      balance as of june 30, 2020
    		                        61,748        
      for the six months ended june 30, 2019:
    		                                
      balance as of january 1, 2019
    		                        63,969  3,291      
      exercise of rights to purchase
    		                        311  52      
      balance as of june 30, 2019
    		                        63,850  5,559      
      for the six months ended june 30, 2018
    		                                
      balance as of january 1, 2018
    		                          2,307      
      exercise of options
    		                          3      
      balance as of june 30, 2018
    		                          3,291      
      gross loss
    		                           -259,750 -1,039,000    
      sales, marketing and general and administrative expenses
    		                           3,405,250 13,621,000    
      for the nine months ended september 30, 2017:
    		                                
      balance as of january 1, 2017
    		                           1,361.5 5,446    
      expiration of warrants and options
    		                                
      balance as of september 30, 2017
    		                           1,665.5 6,662    
      balance as of september 30, 2017- convenience translation into us dollars (nis 3.529 = 1) thousand usd
    		                           472 1,888    
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-06-12 2025-04-30 2024-12-31 2024-11-20 2024-08-20 2024-06-30 2024-06-03 2024-03-21 2023-12-31 2023-09-30 2023-08-21 2023-06-30 2023-06-29 2023-03-31 2022-12-31 2022-12-01 2022-09-01 2022-05-31 2022-03-31 2021-12-31 2021-11-24 2021-09-30 2021-08-18 2021-05-20 2021-03-11 2020-12-31 2020-11-12 2020-08-13 2020-06-30 2020-05-14 2020-03-11 2019-12-31 2019-11-13 2019-09-23 2019-08-14 2019-05-15 2019-03-14 2019-03-11 2018-12-31 2018-11-15 2018-08-06 2018-06-30 2018-05-17 2018-02-15 2017-12-31 2017-11-21 2017-09-30 2017-08-08 2017-06-30 2017-05-16 2017-03-31 2017-03-07 2016-12-31 2016-11-07 2016-09-30 2016-08-24 2016-06-30 2016-05-18 2016-03-31 2015-12-31 
                                                                      
        assets
      		                                                                
        current assets:
      		                                                                
        cash and cash equivalents
      		355,278,000 204,672,000 299,357,000 184,545,000 487,438,000 317,169,000 317,169,000 213,660,000 231,777,000 231,777,000 251,858,000 309,571,000 309,571,000 489,323,000 454,555,000 454,555,000 412,172,000 685,362,000 685,362,000 370,197,000 706,220,000 788,141,000 853,626,000 853,626,000 1,127,778,000 1,127,778,000 1,034,837,000 1,099,057,000   21,020,000 39,665,000 39,665,000 4,509,000   5,466,000 11,601 5,290,000 10,222,000    7,529,000 11,601,000 11,601 14,767           14,243 14,243 5,793 5,793 7,628 7,628 33,811 
        bank deposits
      		8,781,000 168,997,000 105,885,000 253,601,000 257,227,000 440,790,000 440,790,000 547,091,000 532,042,000 532,042,000 541,164,000 541,967,000 541,967,000 383,354,000 499,841,000 499,841,000 573,847,000 346,663,000 346,663,000 650,111,000 511,093,000 459,824,000 437,598,000 437,598,000 257,613,000 257,613,000 286,989,000 296,844,000 85,596,000 85,596,000 16,300,000 9,860,000 9,800,000                                
        marketable equity securities
      		75,719,000 84,154,000 108,585,000 111,203,000                                                             
        restricted bank deposits
      		594,000 123,000                                                               
        trade receivables, net of allowance
      		22,700,000 26,047,000                                                               
        inventory
      		31,703,000 32,878,000 38,616,000 42,524,000 16,832,000 16,899,000 16,899,000 19,510,000 19,289,000 19,289,000 19,698,000 18,390,000 18,390,000 21,276,000 19,546,000 19,546,000 20,040,000 19,400,000 19,400,000 17,837,000 15,982,000 15,063,000 11,199,000 11,199,000 4,035,000 4,035,000 4,120,000 3,164,000 3,314,000 3,314,000 4,032,000 3,956,000 3,956,000 3,679,000 3,543 3,543,000 3,620,000 2,488 3,967,000 3,283,000 3,116 3,543  2,644,000 2,488,000 2,488 2,253 6,874 8,097 6,874 6,874 612 612            
        other current assets
      		10,622,000 8,938,000 7,618,000 7,840,000                                                             
        total current assets
      		505,397,000 525,809,000 582,208,000 657,250,000 778,933,000 789,326,000 789,326,000 797,637,000 800,452,000 800,452,000 831,039,000 893,988,000 893,988,000 909,168,000 991,885,000 991,885,000 1,022,347,000 1,064,318,000 1,064,318,000 1,047,076,000 1,266,411,000 1,276,703,000 1,311,895,000 1,311,895,000 1,394,273,000 1,394,273,000 1,330,294,000 1,401,097,000 676,149,000 676,149,000 42,641,000 54,525,000 54,525,000 10,310,000 9,854 9,854,000 11,923,000 15,390 11,035,000 15,933,000 8,773 9,854  11,996,000 15,390,000 15,390 18,200 52,333 31,974 52,333 52,333 63,184 63,184 35,794 35,794 51,227 51,227 14,555 14,555 6,342 6,342 7,980 7,980 35,341 
        property, plant and equipment
      		23,621,000 24,840,000                                                               
        operating lease right-of-use assets
      		22,487,000 23,789,000                                                               
        deferred tax assets
      		424,000 424,000                                                               
        goodwill
      		 40,388,000 33,356,000 33,356,000                                                             
        intangible assets
      		18,313,000 19,434,000 22,471,000 23,672,000 2,076,000 2,155,000 2,155,000 2,235,000 2,235,000 2,235,000 2,235,000 2,235,000 2,235,000 2,235,000      31,799,000 20,437,000 21,358,000   116,767,000 116,767,000 118,218,000 4,243,000 4,440,000 4,440,000 4,633,000 4,826,000 4,826,000 5,019,000 5,211 5,211,000 5,404,000 6,369 5,597,000 5,790,000 5,983 5,211  6,176,000 6,369,000 6,369 6,562 24,087 23,419 24,087 24,087 24,756 24,756 25,425 25,425 26,095 26,095 7,375 7,375 5,814 5,814 4,503 4,503 11,355 
        other assets
      		1,711,000 1,930,000 1,600,000 1,536,000                                                             
        total assets
      		573,207,000 638,224,000 691,940,000 888,838,000 898,231,000 901,889,000 901,889,000 908,123,000 910,977,000 910,977,000 973,972,000 1,064,338,000 1,064,338,000 1,073,067,000 1,194,152,000 1,194,152,000 1,210,157,000 1,203,458,000 1,203,458,000 1,275,927,000 1,342,429,000 1,387,671,000 1,389,955,000 1,389,955,000 1,523,915,000 1,523,915,000 1,536,151,000 1,490,369,000 689,256,000 689,256,000 63,266,000 66,376,000 66,376,000 22,758,000 22,858 22,858,000 26,719,000 27,336 23,973,000 29,334,000 20,303 22,858 20,303,000 23,725,000 27,336,000 27,336 30,158 93,314 74,524 93,314 93,314 103,762 103,762 73,300 73,300 85,459 85,459 23,459 23,459 13,660 13,660 14,054 14,054 51,538 
        liabilities and equity
      		                                                                
        current liabilities:
      		                                                                
        trade payables
      		12,974,000 11,999,000   30,685,000 4,249,000 4,249,000 3,433,000 2,935,000 2,935,000 4,123,000 4,696,000 4,696,000 8,148,000 3,216,000 3,216,000 5,503,000 3,722,000 3,722,000 2,925,000 3,511,000 3,785,000 2,833,000 2,833,000 1,796,000 1,796,000 1,502,000 1,654,000 776,000 776,000 842,000 669,000 669,000 756,000 850 850,000 487,000 1,162 819,000 1,199,000 1,414 850  1,020,000 1,162,000 1,162 419 6,857 1,775 6,857 6,857 2,868 2,868 4,289 4,289 2,612 2,612 353 353 528 528 465 465 1,727 
        accrued liabilities
      		21,083,000 19,514,000                                                               
        deferred revenue
      		13,250,000 11,873,000 11,572,000 12,014,000                                                             
        current portion of lease liability
      		8,604,000 8,923,000   3,921,000 3,968,000 3,968,000 4,014,000 3,558,000 3,558,000 4,317,000                                                      
        current portion of bank loan
      		156,000 158,000 157,000 157,000 142,000 138,000 138,000 148,000 139,000 139,000 138,000                                                      
        total current liabilities
      		56,067,000 52,467,000 49,761,000 188,818,000 53,546,000 30,816,000 30,816,000 27,837,000 27,006,000 27,006,000 30,415,000 34,472,000 34,472,000 37,007,000 29,274,000 29,274,000 34,070,000 37,033,000 37,033,000 30,348,000 34,506,000 43,482,000 31,996,000 31,996,000 14,541,000 14,541,000 14,770,000 7,103,000 6,686,000 6,686,000 5,262,000 4,347,000 4,347,000 4,203,000 4,425 4,425,000 3,935,000 3,091 3,972,000 4,437,000 3,592 4,425  3,102,000 3,091,000 3,091 2,208 12,794 7,611 12,794 12,794 10,499 10,499 10,380 10,380 7,566 7,566 1,558 1,558 1,522 1,522 1,243 1,243 3,541 
        employee benefits
      		3,666,000 3,697,000 5,333,000 5,340,000 4,827,000 4,700,000 4,700,000 3,941,000 3,698,000 3,698,000 4,009,000 2,773,000 2,773,000 2,468,000 2,485,000 2,485,000 1,561,000 1,462,000 1,462,000 296,000 306,000 4,138,000 4,145,000 4,145,000                                         
        operating lease right-of-use liabilities
      		21,563,000 23,323,000                                                               
        bank loan
      		117,000 158,000   248,000 276,000 276,000 333,000 347,000  380,000                                                      
        long-term settlement payable
      		3,124,000 2,974,000 4,819,000 4,664,000                                                             
        long-term deferred revenue
      		3,226,000 3,617,000 4,075,000 3,993,000                                                             
        total liabilities
      		87,763,000 86,236,000 89,131,000 229,332,000 65,349,000 43,182,000 43,182,000 40,523,000 40,722,000 40,722,000  48,552,000 48,552,000 50,924,000 44,596,000 44,596,000 49,710,000 53,166,000 53,166,000 44,346,000 50,461,000 66,364,000 45,724,000 45,724,000 28,679,000 28,679,000 33,435,000 20,704,000 22,140,000 22,140,000 10,575,000 8,772,000 8,772,000 7,438,000 11,256 11,256,000 15,797,000 4,297 8,916,000 13,189,000 4,731 11,256  4,212,000 4,297,000 4,297 3,420 16,813 11,542 16,813 16,813 14,356 14,356 13,763 13,763 11,241 11,241 2,152 2,152 2,102 2,102 1,619 1,619 4,534 
        commitments and contingencies
      		                                                                
        equity:
      		                                                                
        share capital of nis 5 par value each; 500,000,000 ordinary shares authorized; 207,986,287 and 206,811,875 shares outstanding as of march 31, 2026 and december 31, 2025, respectively, and 280,480,934 and 279,306,522 shares issued as of march 31, 2026 and december 31, 2025, respectively.
      		418,969,000                                                                
        additional paid-in capital
      		1,298,363,000 1,297,323,000                                                               
        treasury stock
      		-192,507,000 -192,507,000                                                               
        accumulated other comprehensive income
      		1,241,000 1,048,000                                                               
        accumulated loss
      		-1,040,622,000 -970,960,000 -937,018,000 -884,013,000 -710,876,000 -687,101,000 -687,101,000 -678,296,000 -669,950,000 -669,950,000 -625,979,000 -591,207,000 -591,207,000 -590,158,000 -523,554,000 -523,554,000 -514,435,000 -536,657,000 -536,657,000 -448,990,000 -382,059,000 -342,327,000 -309,234,000 -309,234,000 -149,610,000 -149,610,000 -131,373,000 -117,771,000 -108,457,000 -108,457,000 -91,018,000 -70,302,000 -70,302,000 -62,037,000 -59,963 -59,963,000 -58,582,000 -44,015 -54,274,000 -53,086,000 -51,610 -59,963 51,610,000 -47,643,000 -44,015,000 -44,015 -40,245 -119,041 -133,609 -119,041 -119,041 -104,391 -104,391 -86,910 -86,910 -70,604 -70,604 -14,840 -14,840 -12,812 -12,812 -11,385 -11,385 -36,134 
        total equity
      		485,444,000 551,988,000   832,882,000 858,707,000 858,707,000 867,600,000 870,255,000 870,255,000 929,279,000 1,015,786,000 1,015,786,000 1,022,143,000 1,149,556,000 1,149,556,000 1,160,447,000 1,150,292,000 1,150,292,000 1,231,581,000 1,291,968,000 1,321,307,000 1,344,231,000 1,344,231,000 1,495,236,000 1,495,236,000 1,502,716,000 1,469,665,000 667,116,000 667,116,000 52,691,000 57,604,000 57,604,000 15,320,000 11,602 11,602,000 10,922,000 23,039 15,057,000 16,145,000 15,572 11,602 15,572,000 19,513,000 23,039,000 23,039 26,738 76,501 62,982 76,501 76,501 89,406 89,406 59,537 59,537 74,218 74,218 21,307 21,307 11,558 11,558 12,435 12,435 47,004 
        total liabilities and equity
      		573,207,000 638,224,000   898,231,000 901,889,000 901,889,000 908,123,000 910,977,000 910,977,000 973,972,000 1,064,338,000 1,064,338,000 1,073,067,000 1,194,152,000 1,194,152,000 1,210,157,000 1,203,458,000 1,203,458,000 1,275,927,000 1,342,429,000 1,387,671,000 1,389,955,000 1,389,955,000 1,523,915,000 1,523,915,000 1,536,151,000 1,490,369,000 689,256,000 689,256,000 63,266,000 66,376,000 66,376,000 22,758,000 22,858 22,858,000 26,719,000 27,336 23,973,000 29,334,000 20,303 22,858  23,725,000 27,336,000 27,336 30,158 93,314 74,524 93,314 93,314 103,762 103,762 73,300 73,300 85,459 85,459 23,459 23,459 13,660 13,660 14,054 14,054 51,538 
        see notes to condensed consolidated financial statements.
      		                                                                
        non-controlling interests
      		    491,000 715,000 715,000 965,000 618,000 618,000 857,000 1,011,000 1,011,000 660,000 892,000 892,000 578,000 767,000 767,000 865,000 553,000 787,000 875,000 875,000 572,000 572,000                                       
        share capital of nis 5 par value each; 500,000,000 ordinary shares authorized; 206,811,875 and 215,777,000 shares outstanding as of december 31, 2025 and december 31, 2024, respectively, and 279,306,522 and 273,847,185 shares issued as of december 31, 2025 and december 31, 2024, respectively.
      		 417,084,000                                                               
        total equity attributable to common shareholders
      		 551,988,000                                                               
        see notes to consolidated financial statements.
      		                                                                
        current assets
      		                                                                
        restricted deposits
      		  60,000 60,000 60,000 537,000 537,000 60,000 60,000 60,000 60,000 60,000 60,000 60,000 60,000 60,000 60,000 60,000 60,000 77,000 77,000 126,000 148,000 148,000 165,000 165,000 167,000 61,000 62,000 62,000 60,000 376,000 60,000 31,000 31 31,000 31,000 20 31,000 31,000 21 31  51,000 20,000 20 20 1,146 369 1,146 1,146 776 776 776 776 500 500 113 113 130 130 133 133 500 
        accounts receivable
      		  22,087,000 25,314,000                                                             
        property and equipment
      		  25,316,000 27,241,000                                                             
        right-of-use assets
      		  25,334,000 32,959,000 8,484,000 9,307,000 9,307,000 10,166,000 10,104,000 10,104,000 11,084,000 12,072,000 12,072,000 12,963,000 14,135,000 14,135,000 15,497,000  16,539,000     4,491,000                                         
        liabilities and stockholders’ equity
      		                                                                
        current liabilities
      		                                                                
        accounts payable
      		  12,087,000 12,012,000                                                             
        accrued expenses
      		  16,102,000 17,518,000                                                             
        short-term settlement payable
      		  1,000,000 1,000,000                                                             
        lease liabilities
      		  8,843,000 9,519,000                                                             
        long-term lease liabilities
      		  24,947,000 26,282,000                                                             
        long-term bank loan
      		  196,000 235,000                                                             
        stockholders’ equity
      		                                                                
        share capital of nis 5 par value each; 500,000,000 ordinary shares authorized; 216,933,812 and 215,777,000 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
      		  417,108,000                                                              
        share premium and capital reserves
      		  1,295,359,000 1,297,822,000 1,300,382,000 1,304,617,000 1,304,617,000 1,303,332,000 1,301,022,000 1,301,022,000 1,298,973,000 1,299,542,000 1,299,542,000 1,299,303,000 1,298,124,000 1,298,124,000 1,300,781,000 1,296,194,000 1,296,194,000 1,291,290,000 1,287,451,000 1,276,443,000 1,266,027,000 1,266,027,000 1,257,980,000 1,257,980,000 1,248,164,000 1,211,920,000 518,426,000 518,426,000 77,535,000 61,748,000 61,748,000 65,216,000 65,202 65,202,000 64,023,000 63,841 63,850,000 63,750,000 63,969 65,202    63,841                   
        treasury shares
      		  -173,264,000 -167,651,000 -167,651,000 -167,651,000 -167,651,000 -167,651,000 -167,651,000 -167,651,000 -149,461,000 -97,896,000 -97,896,000 -89,375,000 -24,768,000 -24,768,000 -19,901,000 -1,509,000 -1,509,000 -1,509,000 -1,509,000 1,509,000 -1,509,000 -1,509,000 -1,509,000 -1,509,000 -1,509,000 -1,509,000 -1,509,000 -1,509,000 -1,509,000 -1,509,000 -1,509,000 -1,509,000 -1,509 -1,509,000 -1,509,000 -1,509 -1,509,000 -1,509,000 -1,509 -1,509  -1,509,000 -1,509,000 -1,509 -1,509 -5,260 -5,260 -5,260 -5,260 -5,260 -5,260 -5,260 -5,260 -5,260 -5,260 -1,400 -1,400 -1,368 -1,368 -1,397 -1,397 -5,260 
        foreign currency translation reserve
      		  2,805,000 2,763,000 1,625,000 1,044,000 1,044,000 2,638,000 1,252,000 1,252,000 1,249,000 2,929,000 2,929,000 938,000 1,176,000 1,176,000 973,000 583,000 583,000     1,407,000                                         
        remeasurement of net defined benefit liability
      		  -2,181,000 -2,181,000 -2,062,000 -2,062,000 -2,062,000 -726,000 -726,000 -726,000 -726,000 707,000 707,000 1,448,000 1,448,000 1,448,000 2,508,000 2,508,000 2,508,000 3,127,000                                             
        total stockholders’ equity
      		  602,809,000 659,506,000                                                             
        total liabilities and stockholders’ equity
      		  691,940,000 888,838,000                                                             
        nano dimensions ltd.
      		                                                                
        condensed consolidated statements of operations
      		                                                                
        for the three and nine months ended september 30, 2025
      		                                                                
        assets held for sale
      		   143,366,000                                                             
        liabilities held for sale
      		   136,598,000                                                             
        share capital of nis 5 par value each; 500,000,000 ordinary shares authorized; 218,362,257 and 215,777,000 shares issued and outstanding as of june 30, 2025 and december 31, 2024, respectively
      		   412,766,000                                                             
        revenue
      		   25,837,000                                                             
        cost of revenue
      		   18,794,000                                                             
        gross profit
      		   7,043,000                                                             
        operating expenses
      		                                                                
        research and development
      		   8,114,000                                                             
        sales and marketing
      		   9,907,000                                                             
        general and administrative
      		   22,190,000                                                             
        restructuring expense
      		   2,101,000                                                             
        desktop metal litigation expense
      		   3,245,000                                                             
        impairment losses
      		   1,456,000                                                             
        total operating expenses
      		   47,013,000                                                             
        income from operations
      		   -39,970,000                                                             
        gain on investment in marketable equity securities
      		   16,288,000                                                             
        income from deconsolidation of subsidiaries
      		   -1,666,000                                                             
        other income
      		   -56,000                                                             
        finance expense
      		   -234,000                                                             
        finance income
      		   14,352,000                                                             
        income before income taxes
      		   -11,286,000                                                             
        income tax benefit
      		   76,000                                                             
        net income from continuing operations
      		   -11,362,000                                                             
        net income from discontinued operations, net of income tax of nil
      		   -169,761,000                                                             
        net income
      		   -181,123,000                                                             
        loss attributable to non-controlling interests
      		   -87,000                                                             
        loss attributable to owners
      		   -181,036,000                                                             
        basic and diluted income per share
      		                                                                
        net income per share
      		   -50                                                             
        trade receivables
      		    12,300,000 9,141,000 9,141,000 12,534,000 12,150,000 12,150,000 11,840,000 12,710,000 12,710,000 10,310,000 12,523,000 12,523,000 10,152,000 6,342,000 6,342,000 5,929,000 5,811,000 6,242,000 3,422,000 3,422,000 1,223,000 1,223,000 852,000 999,000 713,000 713,000 568,000 541,000 541,000 1,482,000 1,816 1,816,000 2,348,000 628 1,174,000 1,855,000 1,313 1,816  1,129,000 628,000 628 591 6 325 6 6     149 149        
        other receivables
      		    5,076,000 4,790,000 4,790,000 4,782,000 5,134,000 5,134,000 6,419,000 11,290,000 11,290,000 4,845,000 5,360,000 5,360,000 6,076,000 6,491,000 6,491,000 2,925,000 6,654,000 7,307,000 5,902,000 5,902,000 3,459,000 3,459,000 3,329,000 972,000 1,126,000 1,126,000 661,000 503,000 503,000 609,000 570 570,000 458,000 653 573,000 542,000 570 570  643,000 653,000 653 569 2,042 2,024 2,042 2,042 4,130 4,130 2,642 2,642 2,979 2,979 312 312 419 419 219 219 1,030 
        investment in securities
      		    94,915,000 86,190,000 86,190,000 80,566,000 81,342,000 81,342,000 112,657,000 138,446,000 138,446,000 131,951,000  172,185,000 160,260,000 114,984,000 114,984,000 139,707,000 20,574,000                                            
        property plant and equipment
      		    13,057,000 14,143,000 14,143,000 16,658,000 15,969,000 15,969,000 16,078,000 16,716,000 16,716,000 14,814,000 14,014,000 14,014,000 10,012,000 5,843,000 5,843,000 13,166,000 11,617,000 9,844,000 7,690,000 7,690,000 7,523,000 7,523,000 6,823,000 5,422,000 5,092,000 5,092,000 4,735,000 4,391,000 4,391,000 4,604,000 4,743 4,743,000 4,979,000 5,248 5,350,000 5,412,000 5,200 4,743  5,194,000 5,248,000 5,248 5,054 16,469 17,930 16,469 16,469 15,397 15,397 11,656 11,656 7,712 7,712 1,416 1,416 1,393 1,393 1,458 1,458 4,414 
        total non-current assets
      		    119,298,000 112,563,000 112,563,000 110,486,000 110,525,000 110,525,000 142,933,000 170,350,000 170,350,000 163,899,000 202,267,000 202,267,000 187,810,000 139,140,000 139,140,000 228,851,000 76,018,000 110,968,000 78,060,000 78,060,000 129,642,000 129,642,000 205,857,000 89,272,000 13,107,000 13,107,000 20,625,000 11,851,000 11,851,000 12,448,000 13,004 13,004,000 14,796,000 11,946 12,938,000 13,401,000 11,530 13,004  11,729,000 11,946,000 11,946 11,958 40,981 42,550 40,981 40,981 40,578 40,578 37,506 37,506 34,232 34,232 8,904 8,904 7,318 7,318 6,074 6,074 16,197 
        liabilities
      		                                                                
        other payables
      		    18,798,000 22,461,000 22,461,000 20,242,000 20,374,000 20,374,000 21,837,000 29,738,000 29,738,000 28,624,000 25,784,000 25,784,000 23,180,000 24,150,000 24,150,000 18,864,000 21,082,000 19,304,000 13,836,000 13,836,000 7,970,000 7,970,000 7,000,000 5,449,000 5,910,000 5,910,000 4,420,000 3,678,000 3,678,000 3,447,000 3,575 3,575,000 3,448,000 1,929 3,153,000 3,238,000 2,178 3,575  2,082,000 1,929,000 1,929 1,789 5,937 5,836 5,937 5,937 7,631 7,631 6,091 6,091 4,954 4,954 1,205 1,205 994 994 778 778 1,814 
        liability in respect of government grants
      		    873,000 843,000 843,000 983,000 2,019,000 2,019,000 1,989,000 1,895,000 1,895,000 1,861,000 1,882,000 1,882,000 1,861,000 1,492,000 1,492,000 1,507,000 1,862,000 1,639,000 1,560,000 1,560,000 1,910,000 1,910,000 1,839,000 754,000 850,000 850,000 883,000 892,000 892,000 937,000 1,044 1,044,000 811,000 934 867,000 873,000 895 1,044  852,000 934,000 934 925 2,921 2,886 2,921 2,921 2,707 2,707 2,181 2,181 2,420 2,420 594 594 580 580 376 376 993 
        long term lease liability
      		    5,855,000   7,429,000 7,652,000 7,652,000 7,900,000                                                      
        total non-current liabilities
      		    11,803,000 12,366,000 12,366,000 12,686,000 13,716,000 13,716,000 44,693,000 14,080,000 14,080,000 13,917,000 15,322,000 15,322,000 15,640,000 16,133,000 16,133,000 13,998,000 15,955,000 22,882,000 13,728,000 13,728,000 14,138,000 14,138,000 18,665,000 13,601,000 15,454,000 15,454,000 5,313,000 4,425,000 4,425,000 3,235,000 6,831 6,831,000 11,862,000 1,206 4,944,000 8,752,000 1,139 6,831 1,139,000 1,110,000 1,206,000 1,206 1,212 4,019 3,931 4,019 4,019 3,857 3,857 3,383 3,383 3,675 3,675        
        equity
      		                                                                
        share capital
      		    410,973,000 409,145,000 409,145,000 407,338,000 405,690,000 405,690,000 404,366,000 400,700,000 400,700,000 399,327,000 396,238,000 396,238,000 389,943,000 388,406,000 388,406,000 387,646,000 387,312,000 386,723,000 386,665,000 386,665,000 386,372,000 386,372,000 386,003,000 375,594,000 257,225,000 257,225,000 66,252,000 66,236,000 66,236,000 12,219,000 6,441 6,441,000 5,559,000 3,291 5,559,000 5,559,000 3,291 6,441  3,291,000 3,291,000 3,291 3,290 6,662 6,682 6,662 6,662 6,662 6,662 5,463 5,463 5,446 5,446 1,411 1,411 1,135 1,135 1,133 1,133 3,863 
        equity attributable to owners of the company
      		    832,391,000 857,992,000 857,992,000 866,635,000 869,637,000 869,637,000 928,422,000 1,014,775,000 1,014,775,000 1,021,483,000 1,148,664,000 1,148,664,000 1,159,869,000 1,149,525,000 1,149,525,000 1,230,716,000 1,291,415,000 1,320,520,000 1,343,356,000 1,343,356,000                                         
        lease liability
      		     6,547,000 6,547,000     8,742,000 8,742,000 9,000,000 10,168,000 10,168,000 11,409,000 12,374,000 12,374,000 10,519,000 10,969,000 12,395,000 3,336,000 3,336,000 3,577,000 3,577,000 3,914,000 3,277,000 2,618,000 2,618,000 1,829,000 1,699,000 1,699,000 1,834,000 2,089 2,089,000 3,476,000  1,273,000 1,381,000  2,089                       
        deferred tax liabilities
      		           75,000 75,000       587,000 279,000 1,101,000 236,000 236,000 3,128,000 3,128,000 3,627,000                                      
        deferred tax
      		             259,000 249,000 249,000 118,000 115,000 115,000  505,000 1,005,000 1,007,000 1,007,000                                         
        liability in respect of warrants
      		              140,000 140,000 123,000 69,000 69,000 124,000 808,000 1,760,000  3,347,000     11,986,000 11,986,000                                   
        loan from banks
      		         347,000  595,000 595,000 588,000 647,000 647,000 686,000 736,000 736,000 785,000 912,000                                            
        financial derivatives and deferred consideration
      		                5,040,000 8,798,000 8,798,000                                              
        current portion of other long-term liability
      		           38,000 38,000 235,000 274,000 274,000 347,000 363,000 363,000 370,000 355,000 416,000 417,000 417,000                                         
        other long-term liabilities
      		                   180,000 819,000 1,849,000 1,104,000 1,104,000              272   244   258,000 272,000 272 287 1,098 1,045 1,098 1,098 1,150 1,150 1,202 1,202 1,255 1,255        
        right of use assets
      		                 16,539,000           3,169,000 3,169,000      2,673,000                             
        other long-term assets
      		                   1,282,000                                             
        right of use asset
      		                   13,972,000 14,172,000 15,142,000 4,491,000  4,869,000 4,869,000 5,225,000 4,103,000   2,478,000 2,258,000 2,258,000 2,459,000 2,673  4,054,000  1,640,000 1,855,000  2,673                       
        financial derivatives
      		                   8,189,000 9,558,000 19,977,000 14,910,000 14,910,000 4,775,000 4,775,000 6,268,000                                      
        presentation currency translation reserve
      		                   -848,000 220,000 1,190,000 1,407,000  1,431,000 1,431,000 1,431,000 1,431,000 1,431,000 1,431,000 1,431,000 1,431,000 1,431,000 1,431,000 1,431 1,431,000 1,431,000 1,431 1,431,000 1,431,000 1,431 1,431  1,431,000 1,431,000 1,431 1,431                  
        liability in respect of warrants and rights of purchase
      		                      3,347,000  5,523,000 5,523,000 9,285,000 9,570,000   2,601,000 1,834,000       2,804,000 6,498,000                         
        cash
      		                            585,338,000 585,338,000     3,894 3,894,000     3,753 3,894 3,753,000     42,265 21,159 42,265 42,265 57,666 57,666 32,376 32,376 47,599 47,599        
        liability in respect of warrants, rights to purchase and convertible notes
      		                                1,834,000                                
        liability in respect of convertible notes and warrants
      		                                 464,000 3,698 3,698,000 7,575,000     3,698                       
        liability in respect of warrants and rights to purchase
      		                                                                
        consolidated statement of financial position data:
      		                                                                
        number of shares outstanding
      		                                          97,098,693,000                      
        share premium
      		                                           59,190,000 58,613,000  57,815 167,572 169,325 167,572 167,572 164,049 164,049 119,579 119,579 118,820 118,820 29,910 29,910 18,976 18,976 18,539 18,539 63,054 
        warrants
      		                                           13,000 13,000  33 1,167 203 1,167 1,167 4,364 4,364 4,364 4,364 4,375 4,375 914 914 896 896 1,228 1,228 6,934 
        capital reserve from transactions with controlling shareholders
      		                                           63,000 63,000  63 1,866 1,866 1,866 1,866 1,866 1,866 1,866 1,866 1,866 1,866 497 497 485 485 495 495 1,866 
        capital reserve for share-based payments
      		                                           4,677,000 5,152,000  5,860 23,535 23,775 23,535 23,535 22,116 22,116 20,435 20,435 19,575 19,575 4,814 4,814 4,246 4,246 3,822 3,822 12,681 
        loans from controlling shareholders
      		                                                                
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-04-30 2024-03-21 2023-03-31 2017-12-31 
               
          cash flow from operating activities
        		       
          net loss
        		-69,662,000   -96,923,000 -55,660,000 -228,295,000  
          adjustments:
        		       
          depreciation, amortization and non-cash lease interest
        		3,701,000       
          impairment losses
        		40,388,000 2,110,000 5,721,000   40,523,000  
          changes in fair value of equity securities
        		8,435,000       
          share-based compensation expense
        		2,925,000       
          changes in assets and liabilities:
        		       
          decrease in inventory
        		425,000 2,178,000  387,000 -340,000 -4,603,000  
          (increase) in other current assets
        		-1,500,000       
          decrease in trade receivables
        		3,258,000 -3,706,000 3,085,000 2,950,000  -1,992,000  
          increasein other payables
        		1,609,000       
          increase in employee benefits
        		-20,000    -1,478,000 1,497,000  
          increase in trade payables
        		1,019,000 611,000 211,000 47,000 1,089,000 628,000 -5,745 
          other
        		2,343,000 -1,963,000 630,000 150,000 164,000 275,000  
          net cash from operating activities
        		-7,079,000 -11,733,000 -7,940,000 -57,010,000 -105,069,000 -92,054,000 -19,287 
          capital expenditures
        		-167,000 0 0 0 0 0 0 
          free cash flows
        		-7,246,000 -11,733,000 -7,940,000 -57,010,000 -105,069,000 -92,054,000 -19,287 
          cash flow relating to investing activities
        		       
          change in bank deposits
        		157,651,000 -63,044,000 143,333,000 100,530,000 -189,060,000 141,555,000  
          purchase of property plant and equipment
        		-167,000       
          net cash from investing activities
        		157,484,000 -63,908,000 65,744,000 140,052,000 -166,600,000 -67,673,000 -1,905 
          cash flow relating to financing activities
        		       
          repayment long-term bank debt
        		-41,000 -38,000 -39,000  -536,000 -406,000  
          net cash from financing activities
        		-41,000 -19,844,000 -5,089,000 -74,447,000 -105,414,000 -5,273,000 461 
          increase in cash, cash equivalents and restricted cash
        		150,364,000       
          effect of exchange rate fluctuations on cash
        		357,000 300,000 953,000 -997,000 1,292,000   
          cash, cash equivalents and restricted cash at beginning of the period
        		206,405,000       
          cash, cash equivalents and restricted cash at end of the period
        		357,126,000       
          supplemental disclosures of cash flow information
        		       
          cash and cash equivalents
        		355,278,000 -94,685,000      
          restricted cash in restricted deposits, current
        		594,000 63,000      
          restricted cash in restricted deposits, non-current
        		1,254,000 -45,000      
          total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows
        		357,126,000       
          non-cash operating and investing activity
        		       
          lease liabilities arising from obtaining right-of-use assets
        		       
          supplemental disclosure of cash flow information
        		       
          income taxes paid during the year
        		       
          see notes to condensed consolidated financial statements.
        		       
          net loss from continuing operations
        		 -33,942,000      
          loss from deconsolidation of subsidiaries
        		 0      
          decrease in other current assets
        		       
          increase in deferred tax assets
        		       
          increase in other payables
        		   -1,150,000 4,856,000 5,281,000 94 
          acquisition of intangible asset
        		   -711,000 -1,524,000   
          acquisition of subsidiaries, net of cash acquired
        		 -10,000 0   -31,057,000  
          deconsolidation of subsidiaries
        		 0 0     
          proceeds from non-controlling interests
        		   555,000 1,089,000 510,000  
          payment of a liability for contingent consideration in a business combination
        		    -9,255,000   
          payments of share price protection recognized in business combination
        		   -363,000 -4,459,000 -1,005,000  
          repurchase of treasury shares
        		 -19,806,000  -69,755,000 -96,387,000   
          cash flow relating to discontinued operations
        		       
          net cash from discontinued operations
        		 928,000 -16,212,000     
          cash, cash equivalents and restricted cash at beginning of the year
        		       
          cash, cash equivalents and restricted cash at end of the year
        		       
          total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows
        		       
          non-cash operating activity
        		       
          intangible asset acquired on credit
        		    711,000   
          property plant and equipment acquired on credit
        		   69,000 214,000 52,000 663 
          non-cash investing activity
        		       
          acquisition replacement awards for pre-combination service
        		       
          see notes to consolidated financial statements.
        		       
          cash flow from operating activities:
        		       
          depreciation, amortization, and non-cash lease interest
        		  6,770,000     
          financing income
        		  -6,576,000     
          interest received
        		  10,035,000 42,806,000 41,529,000 17,465,000  
          loss from revaluation of financial assets and liabilities accounted at fair value
        		       
          share-based payments
        		  1,374,000 13,883,000 20,101,000 32,563,000 583 
          decrease in other receivables
        		   6,078,000    
          decrease in other payables
        		  -2,105,000     
          decrease in employee benefits
        		   -562,000    
          cash flow from investing activities:
        		       
          change in restricted bank deposits
        		  -22,000 -377,000 -27,000 -327,000  
          acquisition of property, plant and equipment
        		  -211,000     
          cash flow from financing activities:
        		       
          cash flows from discontinued operations:
        		       
          decrease in cash and cash equivalents
        		  113,859,000     
          cash and cash equivalents at beginning of the period
        		  0   853,626,000  
          cash and cash equivalents at end of the period
        		  114,812,000     
          non-cash transactions:
        		       
          property, plant and equipment acquired on credit
        		       
          repurchase of treasury shares in trade payables
        		       
          recognition of a right-of-use asset
        		  976,000 1,275,000 929,000 15,196,000  
          income taxes paid during the period
        		  20,000     
          net income from continuing operations
        		       
          (gain) income from revaluation of financial assets and liabilities accounted at fair value
        		       
          income from deconsolidation of subsidiaries
        		       
          decrease (increase) in inventory
        		       
          increase in other receivables
        		    -5,775,000   
          net cash (used in) from investing activities
        		       
          increase in trade receivables
        		    -5,603,000   
          depreciation and amortization
        		   6,675,000 6,544,000 7,283,000 1,514 
          adjustments: - sum
        		   32,163,000 -42,158,000 137,408,000  
          changes in assets and liabilities: - sum
        		   7,750,000  -1,167,000  
          acquisition of property plant and equipment
        		   -2,196,000 -9,098,000 -9,388,000 -1,914 
          lease payments
        		   -4,524,000 -4,823,000 -4,151,000  
          amounts recognized in respect of government grants liability
        		   -180,000 -298,000 -221,000 91 
          increase in cash and cash equivalents
        		   8,595,000 -377,083,000 -165,000,000  
          impairment loss
        		   1,283,000    
          financing income net
        		   -42,183,000 -46,281,000   
          gain from revaluation of financial liabilities accounted at fair value
        		   32,000    
          loss from revaluation of financial assets accounted at fair value
        		   52,256,000    
          loss from disposal of property plant and equipment and right-of-use assets
        		   67,000 326,000   
          decrease in deferred tax
        		    -11,000   
          bank loan repayment
        		   -180,000    
          cash and cash equivalents at beginning of the year
        		   309,571,000 685,362,000   
          cash and cash equivalents at end of the year
        		   317,169,000 309,571,000   
          repurchase of treasury shares on credit
        		       
          net income
        		       
          gain from revaluation of financial assets and liabilities accounted at fair value
        		       
          decrease (increase) in other receivables
        		       
          decrease (increase) in trade receivables
        		       
          increase in deferred tax
        		     -581,000  
          acquisition of financial assets in fair value through profit and loss
        		     -177,775,000  
          decrease in deposit in escrow
        		     3,362,000  
          depreciation
        		       
          increase in cash and cash equivalent s
        		       
          gain from revaluation of financial assets accounted at fair value
        		       
          gain from disposal of property plant and equipment and right-of-use assets
        		       
          increase in inventory
        		      -1,153 
          revaluation of financial liabilities accounted at fair value
        		    461,000 -4,516,000  
          revaluation of financial assets accounted at fair value
        		    -23,462,000 62,791,000  
          net income for the period
        		       
          decrease in trade payables
        		       
          payment of a liability to pay a contingent consideration of business combination
        		     -10,708,000  
          repayment of long-term bank debt
        		       
          income from disposal of property plant and equipment and right-of-use assets
        		       
          proceeds from issuance of ordinary shares, warrants and convertible notes
        		       
          exercise of warrants and options
        		      371 
          conversion of convertible notes and warrants to equity
        		       
          financing expenses
        		     -1,769,000 375 
          increase in cash
        		       
          cash at beginning of the period
        		       
          cash at end of the period
        		       
          property plant and equipment and intangible asset acquired on credit
        		       
          share-based compensation
        		       
          increase (decrease) in trade payables
        		       
          increase (decrease) in cash
        		       
          impairment losses on intangible assets
        		       
          impairment losses on property plant and equipment
        		       
          loss from disposal of property plant and equipment and rou assets
        		       
          change in bank deposits and loans net
        		       
          decrease in pledged deposit
        		       
          decrease in cash
        		       
          cash at beginning of the year
        		       
          loss from disposal of property plant and equipment and right of use assets
        		     948,000  
          fees paid
        		     -109,000  
          (increase) in other receivables
        		     -1,978,000  
          proceeds from sale of property plant and equipment
        		       
          effect of exchange rate fluctuations on cash and cash equivalents
        		     -3,264,000  
          cash and cash equivalents at end of year
        		     685,362,000  
          financing expenses (income)
        		       
          salary expenses paid by non-controlling interest
        		       
          investment in bank deposits and loans
        		       
          investment in shares measured in fair value through profit and loss
        		       
          acquisition of subsidiary, net of cash acquired
        		       
          share-based payment acquired
        		       
          interest and other fees paid
        		       
          acquisition of a right-of-use asset
        		       
          acquisition of financial assets in fair value through profit and loss against credit received
        		       
          salary expenses paid by nci
        		       
          investment in bank deposits
        		       
          share based payment acquired
        		       
          long-term bank debt
        		       
          investment in bank deposits net
        		       
          repayment of bank loans
        		       
          interest paid
        		       
          cash at end of year
        		       
          loss from disposal of property plant and equipment
        		       
          decrease in other long-term liabilities
        		       
          changes in liability in respect of government grants
        		       
          issuance expenses recognized as finance expense
        		       
          loss from disposal and sale of fixed assets
        		       
          cash flow from investing activities
        		       
          increase in bank deposits
        		       
          increase in restricted deposits
        		       
          proceeds from sale of fixed assets
        		       
          cash flow from financing activities
        		       
          proceeds from issuance of ordinary shares, warrants and rights to purchase
        		       
          proceeds from exercise of warrants and rights to purchase
        		       
          cash and cash equivalents at end of period
        		       
          conversion of warrants to equity not for cash
        		       
          changes in liability in respect of warrants and rights to purchase
        		       
          decrease in other long term liabilities
        		       
          decrease in restricted bank deposits
        		       
          exercise of rights to purchase
        		       
          revaluation of liability in respect of government grants
        		      -321 
          increase in other long term liabilities
        		       
          development expenditure capitalized as intangible assets
        		       
          proceeds from issuance of ordinary shares and warrants
        		       
          income from disposal and sale of fixed assets
        		       
          decrease (increase) in restricted bank deposits
        		       
          proceeds from issuance of ordinary shares
        		       
          intangible assets acquired on credit
        		       
          revaluation of controlling shareholders loans
        		       
          revaluation of derivative instruments
        		       
          increase in restricted bank deposits
        		       
          payment of controlling shareholder loans
        		       
          income from disposal of property plant and equipment
        		       
          listing expenses
        		       
          government grants in respect of research and development expenses
        		       
          controlling shareholder wages and accompanying expenses
        		       
          non- cash r&d expenses
        		       
          redemption of restricted bank deposits
        		       
          cash acquired upon reverse acquisition
        		       
          short-term loans received
        		       
          proceeds from controlling shareholder loans
        		       
          property plant and equipment acquired in credit
        		       
          other financing expenses
        		       
          investment in restricted bank deposits
        		       
          decrease in short term deposits